Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ · Healthcare
Ultragenyx Pharmaceutical Inc. Cash on Hand 2016–2025
Ultragenyx Pharmaceutical Inc. annual cash on hand history from 2016 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Ultragenyx Pharmaceutical Inc. cash on hand as of December 31, 2025: 421.0M, a 141.95% increase year-over-year.
- Ultragenyx Pharmaceutical Inc. cash on hand for 2025 were 421.0M, a 141.95% increase from 2024.
- Ultragenyx Pharmaceutical Inc. cash on hand for 2024 were 174.0M, a 18.69% decrease from 2023.
- Ultragenyx Pharmaceutical Inc. cash on hand for 2023 were 214.0M, a 60.97% increase from 2022.
- Ultragenyx Pharmaceutical Inc. cash on hand for 2022 were 132.9M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Ultragenyx Pharmaceutical Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $421 |
| 2024 | $174 |
| 2023 | $214 |
| 2022 | $133 |
| 2021 | $308 |
| 2020 | $714 |
| 2019 | $434 |
| 2018 | $113 |
| 2017 | $100 |
| 2016 | $161 |
Ultragenyx Pharmaceutical Inc. Cash on Hand — FAQ
Ultragenyx Pharmaceutical Inc. (RARE) cash on hand over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RARE's cash on hand history?
The chart and table above show Ultragenyx Pharmaceutical Inc.'s cash on hand by year and by quarter, including the growth rate.